A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)

✍ Scribed by Zhou, Qing; Zhou, Cai-cun; Chen, Gong-yan; Cheng, Ying; Huang, Cheng; Zhang, Li; Xu, Chong-rui; Li, Ai-wu; Yan, Hong-hong; Su, Jian; Zhang, Xu-chao; Yang, Jin-ji; Wu, Yi-long

• Book ID: 122443376
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 661 KB
• Volume: 83
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2013.12.014